Product overview
Defined material for responsible research.
Tirzepatide is a peptide with agonist activity at the GIP and GLP-1 receptors. This 30 mg KM Labs presentation is supplied as a laboratory research material and is not represented as a registered medicine or substitute for a prescribed product.
Published studies have examined tirzepatide in glucose-regulation, appetite-signalling and metabolic research. Those findings relate to defined clinical products and controlled study conditions; they must not be used to infer equivalence, safety or efficacy for this research material.
Common research context — in plain English
In published laboratory, preclinical or controlled clinical research, this material has been investigated in areas such as:
- How combined GIP and GLP-1 receptor activity is investigated
- How these signalling pathways relate to appetite, insulin response, blood-sugar regulation and body-weight change in controlled research
- How the peptide's identity, purity and stability are measured in analytical studies
What this means: these are subjects scientists have studied. They do not prove that this KM Labs research material will produce a benefit, and they are not instructions or claims for human use.
Handling and documentation
Keep sealed, protected from unnecessary light and handled under the storage conditions stated on the product label or batch documentation. Record the product identity, batch reference, date received and storage history.
Certificate of Analysis available upon request.